Circumvent Pharmaceuticals Inc.
Circumvent Pharmaceuticals Inc. is a small business in Portland, OR registered on SAM.gov to bid on federal contracts. It has won 5 small business R&D awards worth $5.1 million through the SBIR and STTR programs since 2017, according to SBIR.gov.
- UEI
- Y14DQ5VD56A7
- CAGE code
- 7JQB4
- SAM.gov registration
- Active
Registration details
| Legal business name | Circumvent Pharmaceuticals Inc. |
|---|---|
| Unique Entity ID (UEI) | Y14DQ5VD56A7 |
| CAGE code | 7JQB4 |
| Location | Portland, OR |
| SAM.gov registration | Active through Jul 28, 2027 |
| Business started | 2015 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | www.circumventpharmaceuticals.com |
SBIR and STTR awards
Circumvent Pharmaceuticals Inc. has won 5 small business R&D awards worth $5.1 million through the SBIR and STTR programs since 2017, 2 of them Phase II and 1 STTR. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Aug 22, 2025 | NIH | SBIR Phase II Development of N-tert-(butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating CLN1… | $1.2 million |
| Sep 20, 2021 | NIH | SBIR Phase II Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile… | $2.9 million |
| Sep 15, 2021 | NIH | STTR Phase I Development of a protein palmitoylation assay to monitor treatment of CLN1 Batten Disease | $304,787 |
| Jul 15, 2021 | NIH | SBIR Phase I Alzheimer's Disease: simultaneous modulation of NMDAR, BACE1, APP and Fyn activity by… | $507,284 |
| Mar 1, 2017 | NIH | SBIR Phase I Development of N tert Butyl hydroxylamine NtBuHA as a therapeutic agent for treating Infantile… | $198,790 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Circumvent Pharmaceuticals Inc. is small under
On its SAM.gov registration, Circumvent Pharmaceuticals Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Circumvent Pharmaceuticals Inc.'s NAICS codes
36 open federal opportunities on SAM.gov use a NAICS code Circumvent Pharmaceuticals Inc. is small under. These are due soonest.
- SURPASS Webinar and Proposers' Day Information
Due in 2 daysOct 12, 2026
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Due in 2 daysOct 12, 2026
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Due in 3 daysOct 14, 2026
- Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United States Biotechnology Leadership
Due in 4 daysOct 15, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
Similar small businesses
Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with Oregon:
- Trace Biosciences Inc, Beaverton, OR
- Cherokee Nation Strategic Programs, L.L.C., Tulsa, OK
- Axle Informatics, LLC, North Bethesda, MD
- Emergent Product Development Gaithersburg Inc., Gaithersburg, MD
- Goldbelt Professional Services, LLC, Chesapeake, VA
- Mapp Biopharmaceutical, Inc., San Diego, CA
Frequently asked questions
What is Circumvent Pharmaceuticals Inc.'s CAGE code?
Circumvent Pharmaceuticals Inc.'s CAGE code is 7JQB4. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Circumvent Pharmaceuticals Inc.'s UEI?
Circumvent Pharmaceuticals Inc.'s Unique Entity ID (UEI) is Y14DQ5VD56A7. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Circumvent Pharmaceuticals Inc.'s SAM.gov registration active?
Yes, as of the latest SAM.gov public data, Circumvent Pharmaceuticals Inc.'s registration is active through Jul 28, 2027. Registrations are renewed every year.
Is Circumvent Pharmaceuticals Inc. a small business?
Circumvent Pharmaceuticals Inc. is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.